ELISA-Based Analysis Reveals an Anti-SARS-CoV-2 Protein Immune Response Profile Associated with Disease Severity

Since the start of the COVID-19 pandemic, many studies have investigated the humoral response to SARS-CoV-2 during infection. Studies with native viral proteins constitute a first-line approach to assessing the overall immune response, but small peptides are an accurate and valuable tool for the fin...

Full description

Bibliographic Details
Main Authors:	Charline Herrscher, Sébastien Eymieux, Christophe Gaborit, Hélène Blasco, Julien Marlet, Karl Stefic, Philippe Roingeard, Leslie Grammatico-Guillon, Christophe Hourioux
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	Journal of Clinical Medicine
Subjects:	SARS-CoV-2 antibodies SARS-CoV-2 linear epitopes COVID-19 disease severity
Online Access:	https://www.mdpi.com/2077-0383/11/2/405

Similar Items

Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach
by: Taimoor Khan, et al.
Published: (2022-04-01)

Multi-Subunit SARS-CoV-2 Vaccine Design Using Evolutionarily Conserved T- and B- Cell Epitopes
by: Burkitkan Akbay, et al.
Published: (2021-06-01)

Comparison of Immunological Profiles of SARS-CoV-2 Variants in the COVID-19 Pandemic Trends: An Immunoinformatics Approach
by: Jenifer Mallavarpu Ambrose, et al.
Published: (2021-05-01)

In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine
by: Mahmoud M. Shehata, et al.
Published: (2021-10-01)

Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2
by: Hong-Zhi Chen, et al.
Published: (2020-07-01)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Siti Naqiah Amrun, et al.
Published: (2020)

In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01)

Secretory Vesicles Are the Principal Means of SARS-CoV-2 Egress
by: Sébastien Eymieux, et al.
Published: (2021-08-01)

COVID-19 Infection, Vaccines, and Immunity—The Antibody Response Requires Detailed Analysis
by: Nigel J. Dimmock
Published: (2021-07-01)

Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
by: Ridhima Kaul, et al.
Published: (2021-10-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

The Advantage of Using Immunoinformatic Tools on Vaccine Design and Development for Coronavirus
by: Jazmín García-Machorro, et al.
Published: (2022-10-01)

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection
by: Meghan E Garrett, et al.
Published: (2022-01-01)

Structural and Phylogenetic Analysis of SARS-CoV-2 Spike Glycoprotein from the Most Widespread Variants
by: Emilia Caputo, et al.
Published: (2022-08-01)

Human Coronavirus Spike Protein Based Multi-Epitope Vaccine against COVID-19 and Potential Future Zoonotic Coronaviruses by Using Immunoinformatic Approaches
by: Zulqarnain Baloch, et al.
Published: (2022-07-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight
by: Chunting He, et al.
Published: (2020-07-01)

Harnessing immunoinformatics for developing a multiple-epitope peptide-based vaccination approach against SARS-CoV-2 spike protein
by: Rehab I. Moustafa, et al.
Published: (2023-06-01)

Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL)
by: Natalia Ruetalo, et al.
Published: (2021-11-01)

Could Mustelids spur COVID-19 into a panzootic?
by: Costanza Manes, et al.
Published: (2020-12-01)

SARS-CoV-2: Searching for the Missing Variants
by: Emilia Caputo, et al.
Published: (2022-10-01)

Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents
by: Naomi S. Coombes, et al.
Published: (2023-02-01)

Comment on Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. <i>Pharmaceutics</i> 2021, <i>13</i>, 502
by: Milad Zandi, et al.
Published: (2022-09-01)

A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status
by: José Manuel Ramos-Rincón, et al.
Published: (2023-10-01)

Mapping IgA Epitope and Cross-Reactivity between Severe Acute Respiratory Syndrome-Associated Coronavirus 2 and DENV
by: Salvatore G. De-Simone, et al.
Published: (2023-11-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Comparative transcriptome analysis of SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E identifying potential IFN/ISGs targets for inhibiting virus replication
by: Yuzhuang Liu, et al.
Published: (2023-12-01)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
by: Ashutosh Khaswal, et al.
Published: (2022-07-01)

SARS, MERS and COVID-19-Associated Renal Pathology
by: Hristo Popov, et al.
Published: (2022-10-01)

Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects
by: Przemyslaw Wielgat, et al.
Published: (2020-08-01)

<i>Betacoronavirus</i> Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic
by: Alejandro Llanes, et al.
Published: (2020-06-01)

An Overview of the Pathogenesis, Transmission, Diagnosis, and Management of Endemic Human Coronaviruses: A Reflection on the Past and Present Episodes and Possible Future Outbreaks
by: Adeoye J. Kayode, et al.
Published: (2021-08-01)

Immune Profiling of COVID-19 in Correlation with SARS and MERS
by: Bariaa A. Khalil, et al.
Published: (2022-01-01)

Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step
by: Clarisse Salgado-Benvindo, et al.
Published: (2023-06-01)

Contribution to pathogenesis of accessory proteins of deadly human coronaviruses
by: Jesus Hurtado-Tamayo, et al.
Published: (2023-05-01)

The biological diversity of coronaviruses: where will the new threat come from?
by: Alexandr Khaitovich, et al.
Published: (2022-05-01)

POTENTIAL RISK OF BRAIN DAMAGE AND POOR DEVELOPMENTAL OUTCOMES IN CHILDREN PRENATALLY EXPOSED TO SARS-COV-2: A SYSTEMATIC REVIEW
by: Marcio Leyser, et al.
Published: (2021-05-01)

Immunogenic SARS-CoV-2 Epitopes: In Silico Study Towards Better Understanding of COVID-19 Disease—Paving the Way for Vaccine Development
by: Vipin Ranga, et al.
Published: (2020-07-01)

Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity
by: Birger Sørensen, et al.
Published: (2020-01-01)